Anti-biotin Antibody, clone F1 | PA007522.h1
Recombinant anti-biotin antibodies and mutants good for in vitro and in vivo studies. The variable regions were not humanized in the human antibody versions.
Recombinant anti-biotin antibodies and mutants good for in vitro and in vivo studies. The variable regions were not humanized in the human antibody versions.
Recombinant mouse IgG1 kappa isotype control and mIgG1 D265A isotype control mutant for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG1 isotype...
Recombinant rat IgG2b kappa isotype control and Fc effector silent rat IgG2b kappa isotype control good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. Mouse variable regions...
Recombinant rat IgG2a kappa isotype control good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. Mouse variable regions and rat IgG2a kappa constant regions.
Cheapest in vivo grade recombinant human IgG1 kappa isotype control and mutants. Low or no specific binding to human samples tested. Humanized variable regions, and human IgG1 kappa constant regions. Chimeric versions and premium grade (endotoxin ≤0.05 EU/mg)...
Recombinant Mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant anti-mouse CD8a monoclonal antibodies from the variable region sequences of the rat anti-mouse CD8a monoclonal antibody (clone number: 2.43) are produced from mammalian cells and good for in vitro and in vivo studies.
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.